Drug Interactions Among Anti-HIV Agents
- Conditions
- HIV Infection
- First Posted Date
- 1999-11-04
- Last Posted Date
- 2008-03-04
- Target Recruit Count
- 22
- Registration Number
- NCT00001766
- Locations
- ๐บ๐ธ
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States
Pharmacodynamics of Intermittent IL-2 Infusions in HIV Seropositive Patients
- Conditions
- HIV Infection
- First Posted Date
- 1999-11-04
- Last Posted Date
- 2008-03-04
- Target Recruit Count
- 36
- Registration Number
- NCT00001474
- Locations
- ๐บ๐ธ
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States
Stem Cell Transplant Following Low-Intensity Chemotherapy to Treat Chronic Granulomatous Disease
- Conditions
- Chronic Granulomatous Disease
- First Posted Date
- 1999-11-04
- Last Posted Date
- 2008-03-04
- Target Recruit Count
- 60
- Registration Number
- NCT00001765
- Locations
- ๐บ๐ธ
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States
Subcutaneously Administered Interleukin-2 Therapy in HIV-Infected Patients
- Conditions
- HIV Infection
- First Posted Date
- 1999-11-04
- Last Posted Date
- 2008-03-04
- Target Recruit Count
- 80
- Registration Number
- NCT00001357
- Locations
- ๐บ๐ธ
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States
Continued Antiretroviral Therapy With Abacavir, Amprenavir and Efavirenz
- Conditions
- HIV Infection
- First Posted Date
- 1999-11-04
- Last Posted Date
- 2008-03-04
- Target Recruit Count
- 25
- Registration Number
- NCT00001758
- Locations
- ๐บ๐ธ
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States
A Phase I/II Study of the Combination of Azidothymidine and Interleukin-2 (IL-2) in the Treatment of HIV-Infected Patients
- Conditions
- HIV Infection
- First Posted Date
- 1999-11-04
- Last Posted Date
- 2008-03-04
- Target Recruit Count
- 73
- Registration Number
- NCT00001282
- Locations
- ๐บ๐ธ
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States
Etanercept to Treat Wegener's Granulomatosis
- Conditions
- VasculitisWegener's Granulomatosis
- First Posted Date
- 1999-11-04
- Last Posted Date
- 2008-03-04
- Target Recruit Count
- 60
- Registration Number
- NCT00001901
- Locations
- ๐บ๐ธ
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States
Analysis of Bronchial Tissue and Fluid in Patients With Wegener's Granulomatosis
- Conditions
- InflammationVasculitisWegener's Granulomatosis
- First Posted Date
- 1999-11-04
- Last Posted Date
- 2008-03-04
- Target Recruit Count
- 25
- Registration Number
- NCT00001541
- Locations
- ๐บ๐ธ
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States
Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory Conditions
- Conditions
- VasculitisWegener's Granulomatosis
- First Posted Date
- 1999-11-04
- Last Posted Date
- 2008-03-04
- Target Recruit Count
- 50
- Registration Number
- NCT00001764
- Locations
- ๐บ๐ธ
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States
Mechanisms of Allergen Immunotherapy
- Conditions
- AsthmaHypersensitivity
- First Posted Date
- 1999-11-04
- Last Posted Date
- 2008-03-04
- Target Recruit Count
- 50
- Registration Number
- NCT00001910
- Locations
- ๐บ๐ธ
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States